Virology

BORNAVIRIDAE FAMILY

Written by MicroDok

Bornaviridae family contains only one genus of virus known as Bornavirus. Bornavirus contain only one species of virus, Borna disease virus – the causative agent of Borna disease (a slow virus infection). Borna disease virus (BDV) is the only viral species in the genus Bornavirus, and they have a ss(-)RNA genome. The ss(-)RNA genome of BDV is converted to a ss(+)RNA genome with the virus’ RNA-dependent RNA Polymerase or replicase that carries out this function. They measure about 90 nm in diameter and BDV are generally enveloped viruses. BDV like the Orthomyxoviruses replicate in the nucleus of their host cell, and they are released via a budding process through the cytoplasmic membrane of the cell. The nucleocapsid of BDV is spherical; and the virus is sensitive to UV light, organic solvents and detergents. The natural hosts of BDV are horses and sheep.

Aside sheep and horses, BDV can also cause infection in a wide variety of other mammals including deer’s, donkeys, shrews, pigs, mules, rats, cattle’s and rabbits and birds. BDV causes lassitude or lethargy, spasm and paralysis in animals especially in horses. And BDV causes a neuropsychiatric disorder in humans. Characteristically, BDV causes infected horses to walk in a staggering manner. Abnormalities in the movement and behavioural patterns of animals infected with BDV are typical characteristics of BD. Infections by BDV in animals and humans are generally asymptomatic in nature. Borna disease (BD) occurs mostly in Europe where the first case of the infection was reported (precisely in a town in Saxony, Germany), but the disease now occur worldwide and have been reported in Africa and Asia.

BDV is highly neurotropic in nature; and this implies that the virus has a high affinity for the nerve cells of the CNS. The affinity of BDV for the nerve cells of its host explains the neuropsychiatric disorder of BD in its host. BDV has the ability to downregulate its replication in vivo or in its host, and this leads to a decrease in the amount of virions that will be produced during an infection. Though the immune system mounts a putative attack against the virus, the low production of infectious virions by BDV allows the pathogen to establish a persistent or chronic infection in its host. Amantadine, an antiviral drug that inhibits the uncoating of viruses is usually used for the treatment of BD in horses, other mammals and humans. The transmission route of BDV still remains largely obscure, and vaccination against BDV infection is available in some economies where the disease is endemic particularly in horses.

SELECTED REFERENCES

Acheson N.H (2011). Fundamentals of Molecular Virology. Second edition. John Wiley and Sons Limited, West Sussex, United Kingdom.

Ahmad K (2002). Norwalk-like virus attacks troops in Afghanistan. Lancet Infect Dis, 2:391.

Alan J. Cann (2005). Principles of Molecular Virology. 4th edition. Elsevier Academic Press,   Burlington, MA, USA.

Alba R, Bosch A and Chillon M (2005). Gutless adenovirus: last-generation adenovirus for gene therapy. Gene Ther, Suppl 12:S18-S27.

Alberts B, Bray D, Johnson A, Lewis J, Raff M, Roberts K and Walter P (1998). Essential Cell Biology: An Introduction to the Molecular Biology of the Cell. Third edition. Garland Publishing Inc., New York.

Balows A, Hausler W, Herrmann K.L, Isenberg H.D and Shadomy H.J (1991). Manual of clinical microbiology. 5th ed. American Society of Microbiology Press, USA.

Barrett   J.T (1998).  Microbiology and Immunology Concepts.  Philadelphia,   PA: Lippincott-Raven Publishers. USA.

About the author

MicroDok

Leave a Comment